Revacept (soluble dimeric glycoprotein VI-Fc fusion protein) - advanceCOR
glenzocimab (ACT 017) - Acticor Biotech
Cablivi (caplacizumab-yhdp) - Sanofi
http://www.ncbi.nlm.nih.gov/pubmed/41804969
 
Siobhan Branfield
 
Mar 10, 2026
 
Prev Next